Mosaic CoMOS
Price$21.55

Qualitative Analysis

Business overview

Business Overview

The Mosaic Company (NYSE: MOS) is a Delaware corporation incorporated in March 2004 and headquartered in Tampa, Florida. It is the world's leading producer and marketer of concentrated phosphate and potash crop nutrients. The company operates through three reportable business segments: Phosphates, Potash, and Mosaic Fertilizantes. Mosaic accounts for approximately 66% of estimated North American annual production of concentrated phosphate crop nutrients and 11% of global annual production. In potash, it accounts for approximately 35% of estimated North American annual production. The Mosaic Fertilizantes segment produces and sells crop nutrients and animal feed ingredients in Brazil, operating mines, chemical plants, blending facilities, and port terminals. Through its Mosaic Biosciences platform, the company is also advancing next-generation biological solutions to improve nutrient use efficiency and crop performance sustainably.

Research as of 29 Jul 2026

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
Brazil phosphate-asset portfolio optimizationEfficiency

Mosaic is idling and demobilizing the Araxá Mining and Chemical Complex, idling related mining activities at Patrocínio, pursuing a sale of the Araxá assets, and continuing technical assessment of the Patrocínio niobium opportunity.

Expected impact: The actions reduce annual Mosaic Fertilizantes phosphate production by approximately 1 million tonnes. Following a potential transaction, Mosaic expects annual capital-expenditure savings of approximately $20-$30 million and annual operating-expense savings of approximately $70-$80 million.

Sign in / Sign up to read more
TimelineAnnounced April 8, 2026; idling and demobilization are in progress, while no completion date for the proposed Araxá sale was disclosed.
Uberaba rare-earths recovery projectInnovation

Mosaic and Rainbow Rare Earths are evaluating recovery of rare-earth elements from phosphogypsum associated with Mosaic's existing phosphate operations in Uberaba, Brazil.

Expected impact: The preliminary assessment contemplated processing approximately 2.7 million tonnes of phosphogypsum annually to produce about 1,900 tonnes of separated neodymium-praseodymium oxide and 600 tonnes of a samarium, europium and gadolinium-rich product.

Sign in / Sign up to read more
TimelineThe parties planned a prefeasibility study followed, subject to favorable results, by a definitive feasibility study targeted for later in 2026. Construction is targeted to start in 2027 and initial production in 2030, subject to studies, approvals, financing and investment decisions.
Renuvis Enzara product launchInnovation

Mosaic Biosciences launched Renuvis Enzara, a residue-management solution using endoglucanase enzyme technology to accelerate decomposition of crop residue, including in cold conditions.

Expected impact: The product expands Mosaic's biological and performance-product portfolio and is intended to improve field readiness, planting conditions, machinery operation and crop establishment without requiring an additional application pass when tank-mixed with compatible inputs.

Sign in / Sign up to read more
TimelineCommercial launch announced August 17, 2026.

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Strategic Partnerships

Rainbow Rare Earths LimitedJoint project development agreement for the Uberaba rare-earths project

The collaboration combines Mosaic's Brazilian phosphate operations and phosphogypsum resource with Rainbow's rare-earth recovery expertise, providing a potential route to extract additional value from existing assets.

Sign in / Sign up to read more
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.